Author: admin

  • Andy Slaughter – 2016 Parliamentary Question to the Department of Health

    Andy Slaughter – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andy Slaughter on 2016-10-11.

    To ask the Secretary of State for Health, if he will publish the names of chair and members of the Specialised Ophthalmology Services Reference Group.

    David Mowat

    Clinical Reference Groups (CRGs) are currently undertaking a process of recruitment. Once all appointments have been made, a full list of members for each CRG will be published on NHS England’s website. However, for the Specialised Ear and Ophthalmology CRG, the Chair and Lead CRG Commissioner have been confirmed as Alison Davis and Nicola Symes respectively.

  • Andy Slaughter – 2016 Parliamentary Question to the Department of Health

    Andy Slaughter – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andy Slaughter on 2016-10-11.

    To ask the Secretary of State for Health, whether NHS England is looking at treatments for Leber’s Hereditary Optic Neuropathy.

    David Mowat

    Treatments for Leber’s Hereditary Optic Neuropathy are not currently within the Specialised Ear and Ophthalmology Clinical Reference Group work programme and there is no current work in the policy pipeline. Any new proposals are able to be submitted to NHS England who would consider in line with their agreed processes for specialised services.

  • Andy Slaughter – 2016 Parliamentary Question to the Department of Health

    Andy Slaughter – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andy Slaughter on 2016-10-11.

    To ask the Secretary of State for Health, what new treatments for Duchenne muscular dystrophy have been notified to the Horizon Scanning Research and Intelligence Centre in the last 12 months.

    Nicola Blackwood

    In the last 12 months, the National Institute for Health Research Horizon Scanning Research and Intelligence Centre has identified and added to its database the following technologies for which Duchenne muscular dystrophy is an indication:

    – ezutromid;

    – FG-3019;

    – follistatin;

    – halofuginone hydrobromide;

    – SRP-4045;

    – SRP-4053; and

    – vamorolone.

  • Norman Lamb – 2016 Parliamentary Question to the Department of Health

    Norman Lamb – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Norman Lamb on 2016-10-11.

    To ask the Secretary of State for Health, what estimate he has made of the total number of supplementary hours worked by pharmacists beyond the hours mandated in the standard NHS contract.

    David Mowat

    The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health under the National Health Service Act 2006. Our assessment considers a range of potential impacts in respect to the adequate provision of NHS pharmaceutical services and access to NHS pharmaceutical services, including supplementary hours and 100 hours per week pharmacies. An impact assessment will be completed to inform final decisions and published in due course.

    Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.

    An impact assessment will be completed to inform final decisions and published in due course.

    Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.

  • Thangam Debbonaire – 2016 Parliamentary Question to the Department of Health

    Thangam Debbonaire – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Thangam Debbonaire on 2016-10-11.

    To ask the Secretary of State for Health, what responsibilities the Government has for delivering services to teenagers and young adults with cancer.

    David Mowat

    Cancer services for teenagers and young adults are delivered by a network of Principle Treatment Centres and Designated Hospitals, commissioned centrally by NHS England. Services include:

    – All cancer chemotherapy and radiotherapy;

    – Specialist palliative care services;

    – Survivorship;

    – Long-term follow up; and

    – Specialist therapies and rehabilitation.

    Cancer services for teenagers and young adults reflect the unique needs of this age group. The delivery of care is arranged similarly to adult services, but there are important differences including the delivery of care in an age-appropriate environment and multi-disciplinary teams include social workers, youth workers, and activity coordinators.

    Services also support teenagers and young adults with the late effects of cancer treatment which particularly affect this age group. Because cancer is a rare condition in this age range, teenage and young adult services work very closely with other agencies to deliver emotional, psychosocial and specialist therapies to support each teenager and young adult to maximise their physical, emotional, cognitive, social and functional potential.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-10-11.

    To ask the Secretary of State for Health, how many pregnant women received treatment from alcohol services in each region of England in each year since 2010.

    Nicola Blackwood

    The data is not published in the requested format.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-10-11.

    To ask the Secretary of State for Health, how many pregnant women in (a) Liverpool Wavertree constituency, (b) Liverpool, (c) the Liverpool City Region and (d) England received treatment from alcohol services in each year since 2010.

    Nicola Blackwood

    The data is not published in the requested format.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-10-11.

    To ask the Secretary of State for Health, what steps his Department is taking to increase the availability of epithalial suspension for people with ulcers.

    Nicola Blackwood

    It is for the National Institute for Health and Care Excellence (NICE) to provide national clinical guidance and advice to improve health and social care based on the latest research and evidence base for use of technology and devices.

    NICE has not made any specific assessment on the use of epithelial suspension for the treatment of ulcers. However, in November 2014 it published medical technologies guidance on The ReCell Spray On Skin system for treating skin loss, scarring and depigmentation after burn injury. This recommended that further research should be carried out before wider adoption could be considered. NICE is due to review this guidance in 2017.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-10-11.

    To ask the Secretary of State for Health, what steps his Department is taking to increase the number of organ donors from ethnic minorities.

    Nicola Blackwood

    There are a number of specific initiatives to increase the number of organ donors from ethnic minorities. Less than 5% of deceased organ donors are from a Black, Asian and Minority Ethnic (BAME) background, yet patients from BAME communities represent around a quarter of people waiting for a transplant.

    The Department works with and supports the National BAME Transplant Alliance to coordinate the work of BAME organisations working within these communities to increase the number of people from a BAME background on the organ donor register and the number of transplants from BAME donors.

    The Department has also funded Kidney Research UK to undertake a Peer Educator Project working with the Pakistani Muslim Community in Birmingham and the Bangladeshi community in Tower Hamlets to raise awareness about organ donation.

    NHS Blood and Transplant (NHSBT) has developed a behaviour change campaign strategy in support of the Taking Organ Transplantation to 2020: A UK Strategy. This includes increasing its education and engagement activities with BAME communities and a Faith Action Plan outlining action to work in partnership with faith leaders. NHSBT also has a wide range of leaflets promoting organ donation that are translated into a number of different South Asian languages including Bengali, Gujarati, Hindi, Punjabi and Urdu.